協和キリンの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2015/01/05 | 1,125 | 1,141 | 1,118 | 1,133 | -3 | -0.3% | 1,199,000 |
| 2014/12/30 | 1,146 | 1,149 | 1,135 | 1,136 | -11 | -1% | 958,000 |
| 2014/12/29 | 1,157 | 1,162 | 1,135 | 1,147 | -3 | -0.3% | 1,031,000 |
| 2014/12/26 | 1,161 | 1,162 | 1,150 | 1,150 | -13 | -1.1% | 784,000 |
| 2014/12/25 | 1,167 | 1,167 | 1,156 | 1,163 | +5 | +0.4% | 1,025,000 |
| 2014/12/24 | 1,167 | 1,168 | 1,152 | 1,158 | +2 | +0.2% | 1,272,000 |
| 2014/12/22 | 1,160 | 1,160 | 1,151 | 1,156 | +11 | +1% | 876,000 |
| 2014/12/19 | 1,173 | 1,175 | 1,140 | 1,145 | -23 | -2% | 2,567,000 |
| 2014/12/18 | 1,164 | 1,173 | 1,158 | 1,168 | +25 | +2.2% | 1,557,000 |
| 2014/12/17 | 1,142 | 1,153 | 1,140 | 1,143 | ±0 | ±0% | 1,490,000 |
| 2014/12/16 | 1,150 | 1,159 | 1,139 | 1,143 | -7 | -0.6% | 1,971,000 |
| 2014/12/15 | 1,173 | 1,175 | 1,147 | 1,150 | -25 | -2.1% | 1,857,000 |
| 2014/12/12 | 1,175 | 1,184 | 1,156 | 1,175 | -37 | -3.1% | 5,664,000 |
| 2014/12/11 | 1,237 | 1,244 | 1,210 | 1,212 | -34 | -2.7% | 2,060,000 |
| 2014/12/10 | 1,264 | 1,272 | 1,243 | 1,246 | -43 | -3.3% | 1,216,000 |
| 2014/12/09 | 1,273 | 1,291 | 1,268 | 1,289 | +4 | +0.3% | 607,000 |
| 2014/12/08 | 1,298 | 1,304 | 1,280 | 1,285 | -11 | -0.8% | 1,066,000 |
| 2014/12/05 | 1,297 | 1,299 | 1,287 | 1,296 | -9 | -0.7% | 797,000 |
| 2014/12/04 | 1,306 | 1,308 | 1,300 | 1,305 | +14 | +1.1% | 592,000 |
| 2014/12/03 | 1,298 | 1,304 | 1,287 | 1,291 | -7 | -0.5% | 952,000 |
| 2014/12/02 | 1,285 | 1,300 | 1,285 | 1,298 | -1 | -0.1% | 722,000 |
| 2014/12/01 | 1,284 | 1,306 | 1,284 | 1,299 | +10 | +0.8% | 794,000 |
| 2014/11/28 | 1,278 | 1,293 | 1,278 | 1,289 | +12 | +0.9% | 825,000 |
| 2014/11/27 | 1,293 | 1,297 | 1,277 | 1,277 | -22 | -1.7% | 655,000 |
| 2014/11/26 | 1,295 | 1,305 | 1,288 | 1,299 | +15 | +1.2% | 1,064,000 |
| 2014/11/25 | 1,325 | 1,328 | 1,284 | 1,284 | -18 | -1.4% | 1,802,000 |
| 2014/11/21 | 1,282 | 1,305 | 1,272 | 1,302 | +24 | +1.9% | 1,521,000 |
| 2014/11/20 | 1,291 | 1,293 | 1,276 | 1,278 | ±0 | ±0% | 789,000 |
| 2014/11/19 | 1,270 | 1,287 | 1,270 | 1,278 | +5 | +0.4% | 1,110,000 |
| 2014/11/18 | 1,275 | 1,282 | 1,264 | 1,273 | +8 | +0.6% | 1,028,000 |
| 2014/11/17 | 1,299 | 1,303 | 1,256 | 1,265 | -47 | -3.6% | 1,235,000 |
| 2014/11/14 | 1,326 | 1,326 | 1,290 | 1,312 | -4 | -0.3% | 2,089,000 |
| 2014/11/13 | 1,300 | 1,319 | 1,297 | 1,316 | +8 | +0.6% | 969,000 |
| 2014/11/12 | 1,300 | 1,322 | 1,299 | 1,308 | +20 | +1.6% | 1,290,000 |
| 2014/11/11 | 1,272 | 1,291 | 1,270 | 1,288 | +14 | +1.1% | 946,000 |
| 2014/11/10 | 1,274 | 1,275 | 1,264 | 1,274 | -6 | -0.5% | 801,000 |
| 2014/11/07 | 1,276 | 1,284 | 1,268 | 1,280 | +6 | +0.5% | 1,037,000 |
| 2014/11/06 | 1,310 | 1,310 | 1,260 | 1,274 | -32 | -2.5% | 1,914,000 |
| 2014/11/05 | 1,284 | 1,310 | 1,284 | 1,306 | +19 | +1.5% | 1,405,000 |
| 2014/11/04 | 1,326 | 1,326 | 1,286 | 1,287 | +15 | +1.2% | 2,065,000 |
| 2014/10/31 | 1,227 | 1,281 | 1,227 | 1,272 | +54 | +4.4% | 2,267,000 |
| 2014/10/30 | 1,223 | 1,231 | 1,217 | 1,218 | -1 | -0.1% | 1,118,000 |
| 2014/10/29 | 1,211 | 1,225 | 1,201 | 1,219 | +21 | +1.8% | 1,544,000 |
| 2014/10/28 | 1,201 | 1,218 | 1,180 | 1,198 | -13 | -1.1% | 759,000 |
| 2014/10/27 | 1,215 | 1,219 | 1,208 | 1,211 | +4 | +0.3% | 785,000 |
| 2014/10/24 | 1,213 | 1,217 | 1,200 | 1,207 | +14 | +1.2% | 1,143,000 |
| 2014/10/23 | 1,200 | 1,207 | 1,186 | 1,193 | -20 | -1.6% | 973,000 |
| 2014/10/22 | 1,190 | 1,213 | 1,190 | 1,213 | +36 | +3.1% | 1,051,000 |
| 2014/10/21 | 1,201 | 1,207 | 1,176 | 1,177 | -32 | -2.6% | 1,172,000 |
| 2014/10/20 | 1,188 | 1,209 | 1,179 | 1,209 | +41 | +3.5% | 1,759,000 |
2601～
2650
件表示中 / 3768件
類似銘柄と比較する
現在ご覧いただいている「協和キリン」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 協和キリン | 263,900円 | -3.5% | -11.3% | 2.27% | 24.24倍 | 1.64倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
| アステラス薬 | 169,200円 | +0.9% | +380.2% | 4.61% | 23.31倍 | 2.00倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 258,000円 | +20.9% | +10.6% | 2.56% | 12.20倍 | 1.61倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 467,600円 | +0.1% | -3.4% | 3.42% | 31.79倍 | 1.57倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
| 小野薬 | 166,100円 | +0.6% | +43.3% | 4.82% | 11.65倍 | 1.00倍 |
|
医療用医薬品専業の中堅。自社開発品多い。先駆的がん免疫阻害剤「オプジーボ」が成長牽引 |
市場注目の銘柄
チャート関連のコラム
